It has been documented that MSCs derived from human cord blood minimized the invasion and migration potential of glioblastoma cell lines by downregulating c-Myc/ERK, PI3K/AKT, and EGFR/c-Met pathways [112]. This evidence concerns the gene MYC and glioblastoma.